Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron versus oral ferrous sulphate for musculoskeletal function in older adults with iron deficiency anaemia
ISRCTN13325706Phase 4Terminated
- Sponsor
- Liverpool Hope University
- Start
- Feb 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial in iron deficiency anemia (IDA) comparing Intravenous iron therapy with Active control oral ferrous sulphate (2 arms). Primary endpoint: Muscle Quality Index at week 24. Started Feb 2023; status: terminated.
02
Drugs
Ironferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ISRCTN13325706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13325706.